Eris Lifesciences Limited

BSE: ERIS540596ISIN INE406M01024

Healthcare
Pharmaceuticals
BSE 500

BSE listing

Share price

₹1,321.25+11.60 (+0.89%)

as of 18 Sep 2026

52W high: ₹1,737.00
52W low: ₹1,237.90
Off 52W high: -23.93%
1M return: -2.00%
3M return: -8.63%
6M return: +2.34%
1Y return: -19.32%
20D avg volume: 10,790
50 DMA: ₹1,367.17
200 DMA: ₹1,405.00

Key ratios Consolidated

Market cap: ₹18,310 Cr
Current price: ₹1,321.25
52W high / low: ₹1,737.00 / ₹1,237.90
Face value: ₹1.00
P/E: 27.50
P/B: —
EPS (TTM): ₹48.04
Book value / share: —
ROE: —
ROCE: 15.70%
Operating margin: —
Net margin: —
Debt / equity: 0.59
Net debt: ₹2,255 Cr
Interest cover: 4.31
Dividend yield: 0.55%
Dividend / share (TTM): ₹7.21
Payout: 15.01%
Cash conversion cycle: 91.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	873.25	756.56	807.45	792.41	773.00	705.30	727.45	738.95	719.72	550.92	486.30	505.30
	2.39	2.23	0.02	2.81	2.69	7.95	4.22	6.77	1.64	15.15	4.20	3.48
	695.75	598.18	645.00	622.83	615.48	584.44	615.51	616.61	606.04	489.43	374.62	382.54
	94.27	68.12	105.85	82.58	70.10	68.28	69.43	72.16	66.47	51.17	38.91	48.17
	131.12	122.97	117.24	146.09	104.26	95.98	133.22	118.35	125.57	58.51	50.03	53.77
	153.42	136.85	138.08	137.45	144.43	121.45	125.39	125.63	132.62	102.47	98.67	98.53
	46.65	45.62	48.82	49.55	48.68	54.28	57.17	59.47	60.37	33.03	18.12	16.30
	72.07	69.57	70.34	69.08	70.51	77.25	81.20	80.48	75.94	53.90	45.72	42.09
	184.36	160.89	164.46	164.34	167.22	161.21	174.87	164.76	156.52	181.84	123.24	131.03
	179.89	160.61	162.47	172.39	160.21	128.81	116.16	129.11	115.32	76.65	115.87	126.24
	0.00	0.00	-17.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	179.89	160.61	145.23	172.39	160.21	128.81	116.16	129.11	115.32	76.65	115.87	126.24
	36.17	119.69	36.52	38.20	36.00	26.52	29.23	32.76	25.90	2.99	14.41	3.92
	143.32	279.10	108.83	134.47	125.10	102.35	86.93	96.35	89.42	79.63	101.46	122.31
	10.28	20.60	7.32	8.82	8.66	6.90	6.15	6.73	6.11	5.22	7.55	9.08
Key metrics
	298.61	275.80	264.39	291.02	279.40	260.34	254.53	269.06	251.63	163.58	179.71	184.63
	34.20%	36.50%	32.70%	36.70%	36.10%	36.90%	35.00%	36.40%	35.00%	29.70%	37.00%	36.50%
	16.40%	36.90%	13.50%	17.00%	16.20%	14.50%	11.90%	13.00%	12.40%	14.50%	20.90%	24.20%
	—	3.90%	—	3.90%	—	3.20%	—	—	—	—	—	—
	13.00%	7.30%	11.00%	7.20%	7.40%	28.00%	49.60%	46.20%	—	—	—	—
	14.60%	172.70%	25.20%	39.60%	39.90%	28.50%	-14.30%	-21.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	3,230	3,129	2,894	2,009	1,685	1,347	1,212	1,074	982.16	855.60
	7.45	7.75	18.36	23.82	11.15	26.09	8.71	15.40	31.69	26.41
	2,562	2,481	2,423	1,602	1,292	930.94	826.07	758.11	696.50	569.78
	350.82	326.65	276.34	177.81	142.20	117.57	99.43	76.88	58.19	47.08
	517.42	490.56	473.12	201.51	206.33	141.72	177.01	73.24	108.93	89.84
	565.80	556.81	505.09	403.81	346.16	252.25	229.30	205.69	190.66	157.32
	190.64	192.67	231.29	84.80	26.17	4.15	1.80	2.16	22.89	10.55
	281.06	279.50	315.46	182.60	117.09	64.70	42.98	50.26	36.35	—
	674.05	656.90	657.36	550.45	449.90	351.32	313.72	328.46	292.89	242.21
	675.36	655.69	488.81	431.24	404.64	442.20	394.50	331.35	317.36	312.23
	-17.24	-17.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	658.12	638.45	488.81	431.24	404.64	442.20	394.50	331.35	317.36	312.23
	230.58	-8.97	114.20	34.19	30.48	36.41	39.36	34.84	26.21	17.25
	665.72	647.51	374.67	397.05	374.16	405.79	355.13	296.51	291.15	294.98
	47.02	45.33	25.85	28.82	28.10	29.89	26.16	21.61	21.15	—
Key metrics
	1,130	1,111	1,036	698.64	547.90	511.05	439.28	383.77	376.60	322.78
	34.98%	35.50%	35.80%	34.80%	32.50%	37.90%	36.20%	35.70%	38.30%	37.70%
	20.61%	20.70%	12.90%	19.80%	22.20%	30.10%	29.30%	27.60%	29.60%	34.50%
	—	15.70%	12.70%	—	—	—	—	—	—	—
	—	8.10%	44.00%	19.20%	25.10%	11.20%	12.80%	9.40%	14.80%	—
	—	72.80%	-5.60%	6.10%	-7.80%	14.30%	19.80%	1.80%	-1.30%	—
	—	241.13	910.01	—	—	—	—	—	—	—
	—	0.83	2.84	—	—	—	—	—	—	—
	—	0.59	0.76	—	—	—	—	—	—	—
	—	2,255	2,278	—	—	—	—	—	—	—
	—	91.9	58.2	—	—	—	—	—	—	—
Balance sheet
	—	7,366	7,033	—	—	—	—	—	—	—
	—	1,540	1,263	—	—	—	—	—	—	—
	—	54.74	199.74	—	—	—	—	—	—	—
	—	680.34	458.64	—	—	—	—	—	—	—
	—	436.82	334.83	—	—	—	—	—	—	—
	—	293.56	192.73	—	—	—	—	—	—	—
	—	708.37	662.07	—	—	—	—	—	—	—
	—	329.65	332.35	—	—	—	—	—	—	—
	—	2,077	1,381	—	—	—	—	—	—	—
	—	2,310	2,478	—	—	—	—	—	—	—
	—	1,354	696.20	—	—	—	—	—	—	—
	—	955.83	1,782	—	—	—	—	—	—	—
	—	3,896	3,272	—	—	—	—	—	—	—
Cash flow
	—	537.99	1,065	—	—	—	—	—	—	—
	—	-369.46	-79.97	—	—	—	—	—	—	—
	—	-313.53	-881.32	—	—	—	—	—	—	—
	—	296.86	155.00	—	—	—	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	443.99	277.31	315.29	650.50	578.64	404.77	399.73	428.75	456.69	341.30	324.41	409.71
	26.38	26.97	25.07	23.59	22.68	16.75	7.79	13.62	5.16	20.39	3.43	6.97
	406.23	337.05	321.80	439.42	445.06	380.34	401.49	396.35	435.03	319.94	293.20	296.76
	19.99	22.53	17.05	20.29	24.12	9.83	10.93	23.19	24.40	17.74	23.75	28.64
	128.10	122.95	113.75	134.83	106.69	119.02	122.67	112.34	120.41	37.17	36.24	51.43
	90.84	78.67	82.75	85.42	93.78	81.41	87.04	89.72	103.75	79.52	80.69	81.10
	42.16	42.70	45.20	46.50	45.14	53.16	54.65	56.26	56.17	28.89	15.14	6.54
	39.98	38.82	38.66	39.30	37.60	43.38	46.68	46.16	45.55	29.14	28.08	25.00
	72.44	39.10	45.16	70.81	87.02	78.07	94.04	78.88	99.04	117.08	104.65	107.00
	64.14	-32.77	18.56	234.67	156.26	41.18	6.03	46.02	26.82	41.75	34.64	119.92
	0.00	0.00	-14.67	0.00	0.00	0.00	—	—	—	—	—	—
	64.14	-32.77	3.89	234.67	156.26	41.18	6.03	46.02	26.82	41.75	34.64	119.92
	15.84	-24.17	0.80	85.10	56.27	10.71	4.25	17.92	9.78	2.24	2.99	2.11
	48.30	-8.60	3.09	149.57	99.99	30.47	1.78	28.10	17.04	39.51	31.66	117.81
	3.49	-0.63	0.23	10.98	7.34	2.24	0.13	2.06	1.25	2.90	2.33	8.66
Key metrics
	146.28	48.75	87.75	320.47	239.00	137.72	107.36	148.44	128.54	99.78	77.86	151.46
	32.90%	17.60%	27.80%	49.30%	41.30%	34.00%	26.90%	34.60%	28.10%	29.20%	24.00%	37.00%
	10.90%	-3.10%	1.00%	23.00%	17.30%	7.50%	0.40%	6.60%	3.70%	11.60%	9.80%	28.80%
	—	0.20%	—	6.50%	—	2.20%	—	—	—	—	—	—
	-23.30%	-31.50%	-21.10%	51.70%	26.70%	18.60%	23.20%	4.60%	—	—	—	—
	-51.70%	-128.20%	73.60%	432.30%	486.80%	-22.90%	-94.40%	-76.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	1,687	1,822	1,698	1,487	1,331	1,216	1,109	1,020	896.54	760.60
	102.01	98.31	35.51	34.83	17.26	28.99	10.00	14.73	32.50	28.22
	1,504	1,543	1,613	1,193	911.08	786.18	729.94	711.37	617.26	476.94
	79.86	83.99	68.35	96.29	114.13	117.57	99.43	76.88	58.19	47.08
	499.63	478.22	474.44	197.02	113.76	79.59	111.65	70.00	87.56	64.89
	337.68	340.62	361.92	331.67	252.52	222.18	207.02	191.73	166.77	130.84
	176.56	179.54	220.24	57.42	20.81	2.99	0.78	1.85	22.79	10.43
	156.76	154.38	181.77	102.39	64.66	51.45	37.64	44.88	31.59	21.79
	227.51	242.09	350.03	421.06	336.71	309.90	285.99	308.54	263.76	205.44
	284.60	376.72	120.05	328.83	436.91	458.54	388.89	323.59	311.78	311.89
	-14.67	-14.67	0.00	—	—	—	—	—	—	—
	269.93	362.05	120.05	328.83	436.91	458.54	388.89	323.59	311.78	311.89
	77.57	118.00	42.66	29.12	38.90	41.35	38.29	32.32	26.39	18.23
	192.36	244.05	77.39	299.71	398.01	417.19	350.61	291.27	285.38	293.65
	14.07	17.86	5.69	22.04	29.27	30.70	25.82	21.23	20.75	—
Key metrics
	603.25	695.97	522.06	488.64	522.38	512.98	427.31	370.32	366.16	344.11
	35.76%	38.20%	30.80%	32.90%	39.30%	42.20%	38.50%	36.30%	40.80%	45.20%
	11.40%	13.40%	4.60%	20.20%	29.90%	34.30%	31.60%	28.50%	31.80%	38.60%
	—	13.30%	8.00%	—	—	—	—	—	—	—
	—	7.30%	14.20%	11.70%	9.50%	9.60%	8.70%	13.80%	17.90%	—
	—	215.40%	-74.20%	-24.70%	-4.60%	19.00%	20.40%	2.10%	-2.80%	—
	—	514.55	694.25	—	—	—	—	—	—	—
	—	2.31	9.07	—	—	—	—	—	—	—
	—	0.65	0.88	—	—	—	—	—	—	—
	—	2,050	2,129	—	—	—	—	—	—	—
	—	41.9	45.4	—	—	—	—	—	—	—
Balance sheet
	—	5,778	5,222	—	—	—	—	—	—	—
	—	1,023	627.54	—	—	—	—	—	—	—
	—	25.18	84.34	—	—	—	—	—	—	—
	—	307.16	236.19	—	—	—	—	—	—	—
	—	121.36	191.25	—	—	—	—	—	—	—
	—	63.21	86.43	—	—	—	—	—	—	—
	—	124.19	107.17	—	—	—	—	—	—	—
	—	219.35	216.08	—	—	—	—	—	—	—
	—	1,718	993.94	—	—	—	—	—	—	—
	—	2,076	2,213	—	—	—	—	—	—	—
	—	1,278	580.31	—	—	—	—	—	—	—
	—	797.62	1,633	—	—	—	—	—	—	—
	—	3,195	2,515	—	—	—	—	—	—	—
Cash flow
	—	563.94	701.87	—	—	—	—	—	—	—
	—	-694.16	-358.99	—	—	—	—	—	—	—
	—	71.06	-310.47	—	—	—	—	—	—	—
	—	49.39	7.62	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +11.04%
Sales CAGR 5Y: +10.44%
Sales CAGR 10Y: —
Profit CAGR 3Y: -15.04%
Profit CAGR 5Y: -6.99%
Profit CAGR 10Y: —
Sales YoY (TTM): -6.89%
Profit YoY (TTM): +19.97%

Consolidated

Sales CAGR 3Y: +22.92%
Sales CAGR 5Y: +20.89%
Sales CAGR 10Y: —
Profit CAGR 3Y: +20.06%
Profit CAGR 5Y: +12.76%
Profit CAGR 10Y: —
Sales YoY (TTM): +9.68%
Profit YoY (TTM): +62.08%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 54.14%

Holder	Type	Holding	Previous	Change
Amit Indubhusan Bakshi	Promoter	42.34%	—	—
Lilac Investments Limited	Public	8.63%	—	—
Hdfc Small Cap Fund	Public	8.33%	—	—
Franklin India Small Cap Fund	Public	4.29%	—	—
Inderjeet Singh Negi	Promoter	4.29%	—	—
Rajendrakumar Rambhai Patel	Promoter	4.29%	—	—
Kaushal Kamleshkumar Shah	Promoter	3.22%	—	—
Hetal Rasiklal Shah	Public	2.12%	—	—
Bhikhalal Chimanlal Shah	Public	1.93%	—	—
Naishadh Vikram Shah	Public	1.66%	—	—
Uti-Flexi Cap Fund	Public	1.58%	—	—
Rakesh Shah	Public	1.43%	—	—
Hsbc Mutual Fund - Hsbc Small Cap Fund	Public	1.03%	—	—
Saanvi Kaushal Shah	Promoter Group	0.00%	—	—
Horizon Blue Ventures LLP	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

As Attached11 Sep 2026 · Company Update / Resignation of Director
Eris Lifesciences Limited has informed the exchange about Rumor verification-Regulation 30 (11)10 Sep 2026 · Company Update / General
As attached9 Sep 2026 · Company Update / General
As Attached7 Sep 2026 · Company Update / Analyst / Investor Meet
as attached3 Sep 2026 · Company Update / Newspaper Publication
as attached.2 Sep 2026 · Company Update / Newspaper Publication
as attached2 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
as attached2 Sep 2026 · Others / Reg. 34 (1) Annual Report
as attached2 Sep 2026 · AGM/EGM / AGM
As Attached31 Aug 2026 · Others / Outcome without intimation
As Attached24 Aug 2026 · Company Update / Analyst / Investor Meet
as attached12 Aug 2026 · Company Update / Analyst / Investor Meet
As Attached10 Aug 2026 · Company Update / Analyst / Investor Meet
as attached6 Aug 2026 · Company Update / General
As Attached4 Aug 2026 · Company Update / Earnings Call Transcript
As Attached30 Jul 2026 · Company Update / Analyst / Investor Meet
As Attached30 Jul 2026 · Company Update / Allotment of ESOP / ESPS
As Attached29 Jul 2026 · Company Update / Analyst / Investor Meet
as attached29 Jul 2026 · Company Update / Investor Presentation
as attached29 Jul 2026 · Result / Financial Results
as attached29 Jul 2026 · Board Meeting / Outcome of Board Meeting
As Attached23 Jul 2026 · Company Update / Analyst / Investor Meet
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the financial results for ....23 Jul 2026 · Board Meeting / Board Meeting
As attached9 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As attached26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
as attached26 Jun 2026 · Company Update / Allotment of ESOP / ESPS
as attached23 Jun 2026 · Company Update / General
As Attached8 Jun 2026 · Others / Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
As Attached28 May 2026 · Company Update / General
As Attached27 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
As Attached26 May 2026 · Company Update / Earnings Call Transcript
as attached25 May 2026 · AGM/EGM / Postal Ballot
as attached25 May 2026 · AGM/EGM / Postal Ballot
As Attached25 May 2026 · Company Update / Analyst / Investor Meet
as attached20 May 2026 · Company Update / Analyst / Investor Meet
as attached20 May 2026 · Company Update / Investor Presentation
as attached20 May 2026 · Corp Action / Date of payment of Dividend
as attached20 May 2026 · Corp. Action / Dividend
as attached20 May 2026 · Result / Financial Results
as attached20 May 2026 · Board Meeting / Outcome of Board Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend - Rs. - 7.2100	29 May 2026	29 May 2026	—
Interim Dividend - Rs. - 7.3500	13 Feb 2025	13 Feb 2025	—

Board meetings

29 Jul 2026 Board Meeting - Financial Results